EC
PHVS icon

EcoR1 Capital’s Pharvaris PHVS Stock Holding History

EcoR1 Capital’s Portfolio PHVS Stock Details PHVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-900,000
Closed -$16.7M – 70
2024
Q3 		$16.7M Hold
900,000
– – 0.57% 37
2024
Q2 		$16.9M Hold
900,000
– – 0.52% 38
2024
Q1 		$20.8M Hold
900,000
– – 0.53% 34
2023
Q4 		$25.2M Buy
+900,000
New +$18.2M 0.66% 27

Other funds holding PHVS

GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

EcoR1 Capital's PHVS Position: Q4 2024 in Review

EcoR1 Capital sold out of Pharvaris (PHVS) in Q4 2024, closing a stake of 900,000 shares — an estimated $16.7M sold.

EcoR1 Capital first reported a position in PHVS in Q4 2023 and held it in 4 quarters. The position peaked at $25.2M in Q4 2023. 54 funds tracked by Wall St. Rank hold PHVS as of Q4 2024.

  • EcoR1 Capital reported no remaining Pharvaris position as of Q4 2024 after selling out during the quarter.
  • EcoR1 Capital sold 900,000 Pharvaris shares in Q4 2024, an estimated $16.7M.
  • EcoR1 Capital first reported a position in Pharvaris in Q4 2023 and held it in 4 quarters.
  • EcoR1 Capital's Pharvaris position peaked at $25.2M in Q4 2023.
  • 54 funds tracked by Wall St. Rank held Pharvaris as of Q4 2024.

Based on EcoR1 Capital's 13F filing for Q4 2024, filed 14 Feb 2025.